Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

185 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

NCT00043368

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +40 more
Locations
  • Pfizer Investigational Site Berkely, California, United States
  • Pfizer Investigational Site Gilroy, California, United States
  • Pfizer Investigational Site Hollister, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View all 32 locations
View Trial Details
Completed

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

NCT00211198

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • The University of Iowa Iowa City, Iowa, United States
  • New England Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions